- Is Translational Research Cancer Center Consortium a tax-exempt 501(c)(3)?
- Yes. Translational Research Cancer Center Consortium is recognised by the IRS as a 501(c)(3) organisation (EIN 83-1794049). The IRS recognised Translational Research Cancer Center Consortium as tax-exempt in February 2021.
- What is Translational Research Cancer Center Consortium's EIN?
- Translational Research Cancer Center Consortium's Employer Identification Number (EIN) is 83-1794049. The EIN was assigned by the IRS in February 2021. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Translational Research Cancer Center Consortium do?
- Dissemination of information regarding the prevention, treatment, and cure of cancer, integrating cancer biology and tumor immunology. Promoting research, clinical collaborations, enhanced partnerships with industry, and training of the next generation of scientists.
- Where is Translational Research Cancer Center Consortium located?
- Translational Research Cancer Center Consortium is located at co 1227 South Braddock Avenue, Pittsburgh, PA, 15218.
- When was Translational Research Cancer Center Consortium founded or recognised by the IRS?
- Translational Research Cancer Center Consortium was recognised by the IRS as a tax-exempt organisation in February 2021. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Translational Research Cancer Center Consortium's annual revenue?
- On its most recent Form 990 (fiscal year 2024), Translational Research Cancer Center Consortium reported $240K in total revenue and $122K in total expenses.
- Has Translational Research Cancer Center Consortium been auto-revoked by the IRS?
- No. Translational Research Cancer Center Consortium (EIN 83-1794049) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Translational Research Cancer Center Consortium listed in IRS Publication 78?
- Yes. Translational Research Cancer Center Consortium is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
